celecoxib has been researched along with minocycline in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 6 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Andrews, H; Barohn, RJ; Bedlack, R; Bednarz, K; Belsh, JM; Boylan, K; Chapin, J; Cheung, YK; Doorish, C; Florence, J; Gordon, PH; Graves, M; Kelvin, EA; Levin, B; Levine, T; Lou, JS; Macarthur, RB; McCluskey, LF; Miller, RG; Mitsumoto, H; Montes, J; Mozaffar, T; Pestronk, A; Rivner, M; Rowin, J; Saperstein, D; Scelsa, SN; Sorenson, EJ; Tandan, R | 1 |
| Cai, L; Liao, Z; Niu, G; Sun, L; Wei, R | 1 |
| Beer, K | 1 |
| Davis, JM; Torrey, EF | 1 |
| Grieg, Z; Langmoen, IA; Sandberg, CJ; Skaga, E; Skaga, IØ; Vik-Mo, EO | 1 |
| Iqbal, Z; Jain, P; Mirza, MA | 1 |
| Berk, M; Dean, OM; Vieta, E | 1 |
| Ansari, MA; Carvalho, AF; Chaudhry, IB; Deakin, B; Hodsoll, J; Husain, MI; Husain, MO; Husain, N; Khoso, AB; Meyer, JH; Minhas, FA; Mulsant, BH; Naqvi, HA; Young, AH | 1 |
| Miller, AH; Pariante, CM | 1 |
| Chaudhry, IB; Deakin, B; Husain, MI; Mulsant, BH; Young, AH | 1 |
| Alam, M; Farooq, U; Iqbal, Z; Jain, P; Kuruniyan, MS; Mirza, MA; Nainwal, LM; Poonkuzhi, NP | 1 |
| Arteaga-Henríquez, G; Gisbert, L; Ramos-Quiroga, JA | 1 |
3 review(s) available for celecoxib and minocycline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aspirin; Benzothiazoles; Bipolar Disorder; Celecoxib; Chemotherapy, Adjuvant; Cyclooxygenase 2 Inhibitors; Dopamine Agonists; Estrogens; Fatty Acids, Omega-3; Folic Acid; Humans; Mianserin; Minocycline; Mirtazapine; Pramipexole; Pregnenolone; Pyrazoles; Randomized Controlled Trials as Topic; Schizophrenia; Sulfonamides; Treatment Outcome; Vitamin B Complex | 2012 |
Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Autism Spectrum Disorder; Celecoxib; Fatty Acids, Omega-3; Humans; Immunologic Factors; Minocycline; Prednisolone; Randomized Controlled Trials as Topic | 2023 |
2 trial(s) available for celecoxib and minocycline
| Article | Year |
|---|---|
A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Celecoxib; Creatine; Double-Blind Method; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Neuroprotective Agents; Patient Selection; Pyrazoles; Sulfonamides; Treatment Outcome | 2008 |
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bipolar Disorder; Case-Control Studies; Celecoxib; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Pakistan; Placebos; Psychiatric Status Rating Scales; Treatment Outcome | 2020 |
9 other study(ies) available for celecoxib and minocycline
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The combined effects of celecoxib and minocycline hydrochloride on inhibiting the osseous metastasis of breast cancer in nude mice.
Topics: Alkaline Phosphatase; Animals; Apoptosis; Body Weight; Bone Neoplasms; Breast Neoplasms; Celecoxib; Cell Line, Tumor; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Matrix Metalloproteinase 9; Mice; Mice, Inbred Strains; Mice, Nude; Minocycline; Pyrazoles; Sulfonamides; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2008 |
Delayed onset nodules from liquid injectable silicone: report of a case, evaluation of associated histopathology and results of treatment with minocycline and celocoxib.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Drug Therapy, Combination; Female; Foreign-Body Migration; Granuloma, Foreign-Body; Humans; Injections; Middle Aged; Minocycline; Pyrazoles; Silicones; Sulfonamides; Time Factors | 2009 |
The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Auranofin; Brain Neoplasms; Captopril; Celecoxib; Disulfiram; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Glioblastoma; Humans; Itraconazole; Mice; Mice, SCID; Minocycline; Neoplastic Stem Cells; Quetiapine Fumarate; Reproducibility of Results; Sertraline; Signal Transduction; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
A 4-D approach for amelioration of periodontitis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Combined Modality Therapy; Cyclooxygenase Inhibitors; Doxycycline; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Durapatite; Gingiva; Humans; Matrix Metalloproteinase Inhibitors; Minocycline; Models, Biological; Osseointegration; Periodontics; Periodontitis; Regeneration; Substance-Related Disorders | 2019 |
Anti-inflammatory treatment of bipolar depression: promise and disappointment.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antirheumatic Agents; Biomarkers; Bipolar Disorder; C-Reactive Protein; Celecoxib; Clinical Trials as Topic; Depression; Humans; Inflammation; Infliximab; Minocycline | 2020 |
Trial failures of anti-inflammatory drugs in depression.
Topics: Anti-Inflammatory Agents; Bipolar Disorder; Celecoxib; Depression; Humans; Minocycline | 2020 |
Trial failures of anti-inflammatory drugs in depression - Authors' reply.
Topics: Anti-Inflammatory Agents; Bipolar Disorder; Celecoxib; Depression; Humans; Minocycline | 2020 |
Topics: Anti-Bacterial Agents; Celecoxib; Doxycycline; Humans; Hydroxyapatites; Matrix Metalloproteinase 13; Matrix Metalloproteinase 8; Matrix Metalloproteinase Inhibitors; Metronidazole; Minocycline; Molecular Docking Simulation; Osteopontin; Periodontitis; Simvastatin | 2022 |